WO2000069424A3 - Method of treating psychotic disorders - Google Patents
Method of treating psychotic disorders Download PDFInfo
- Publication number
- WO2000069424A3 WO2000069424A3 PCT/EP2000/003506 EP0003506W WO0069424A3 WO 2000069424 A3 WO2000069424 A3 WO 2000069424A3 EP 0003506 W EP0003506 W EP 0003506W WO 0069424 A3 WO0069424 A3 WO 0069424A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- psychotic disorders
- treating psychotic
- activity
- relates
- treating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000617883A JP2002544223A (en) | 1999-05-12 | 2000-04-14 | How to treat psychotic disorders |
EP00926982A EP1200072A2 (en) | 1999-05-12 | 2000-04-14 | Method of treating psychotic disorders |
CA002373855A CA2373855A1 (en) | 1999-05-12 | 2000-04-14 | Method of treating psychotic disorders |
AU45522/00A AU4552200A (en) | 1999-05-12 | 2000-04-14 | Method of treating psychotic disorders |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99201524 | 1999-05-12 | ||
EP99201524.8 | 1999-05-12 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2000069424A2 WO2000069424A2 (en) | 2000-11-23 |
WO2000069424A3 true WO2000069424A3 (en) | 2001-06-07 |
Family
ID=8240207
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2000/003506 WO2000069424A2 (en) | 1999-05-12 | 2000-04-14 | Method of treating psychotic disorders |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1200072A2 (en) |
JP (1) | JP2002544223A (en) |
AU (1) | AU4552200A (en) |
CA (1) | CA2373855A1 (en) |
WO (1) | WO2000069424A2 (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR028685A1 (en) | 2000-06-14 | 2003-05-21 | Lundbeck & Co As H | INDOL DERIVATIVES |
DE102004023632A1 (en) * | 2004-05-10 | 2005-12-08 | Grünenthal GmbH | Substituted cyclohexylcarboxylic acid derivatives |
DE102004023506A1 (en) * | 2004-05-10 | 2005-12-01 | Grünenthal GmbH | Chain-extended substituted cyclohexyl-1,4-diamine derivatives |
DE102004023507A1 (en) * | 2004-05-10 | 2005-12-01 | Grünenthal GmbH | Substituted cyclohexylacetic acid derivatives |
DE102004023635A1 (en) * | 2004-05-10 | 2006-04-13 | Grünenthal GmbH | Heteroaryl-substituted cyclohexyl-1,4-diamine derivatives |
DE102004023501A1 (en) * | 2004-05-10 | 2005-12-01 | Grünenthal GmbH | Oxo-substituted cyclohexyl-1,4-diamine derivatives |
DE102004023508A1 (en) * | 2004-05-10 | 2005-12-08 | Grünenthal GmbH | Acid derivatives of substituted cyclohexyl-1,4-diamine |
DE102004023522A1 (en) * | 2004-05-10 | 2005-12-01 | Grünenthal GmbH | Substituted cyclohexyl-1,4-diamine derivatives |
ATE443707T1 (en) * | 2004-11-26 | 2009-10-15 | Janssen Pharmaceutica Nv | ISOXAZOLINE INDOLE DERIVATIVES WITH IMPROVED ANTIPSYCHOTIC AND ANXIOLYTIC ACTIVITY |
KR20070091009A (en) * | 2004-12-07 | 2007-09-06 | 솔베이 파마슈티칼스 비. 브이 | Tetrahydropyridin-4-yl indoles with a combination of affinity for dopamine-d2 receptors and serotonin reuptake sites |
US7371769B2 (en) | 2004-12-07 | 2008-05-13 | Solvay Pharmaceuticals B.V. | Tetrahydropyridin-4-yl indoles with a combination of affinity for dopamine-D2 receptors and serotonin reuptake sites |
US8101619B2 (en) | 2004-12-08 | 2012-01-24 | Solvay Pharmaceuticals B.V. | Phenylpiperazine derivatives with a combination of partial dopamine-D2 receptor agonism and serotonin reuptake inhibition |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992012977A1 (en) * | 1991-01-28 | 1992-08-06 | Warner-Lambert Company | Substituted indoles as central nervous system agents |
EP0560669A1 (en) * | 1992-03-11 | 1993-09-15 | Bristol-Myers Squibb Company | Piperazinyl-and piperidinyl-cyclohexenes and cyclohexanes |
DE4414113A1 (en) * | 1994-04-22 | 1995-10-26 | Merck Patent Gmbh | 3-indolylpiperidines |
EP0722942A1 (en) * | 1995-01-12 | 1996-07-24 | MERCK PATENT GmbH | Indole piperidine derivatives |
WO1997017343A1 (en) * | 1995-11-06 | 1997-05-15 | American Home Products Corporation | Indolealkyl derivatives of benzodioxanmethylamine as 5-ht1a receptor ligands |
EP0830864A1 (en) * | 1996-09-23 | 1998-03-25 | Eli Lilly And Company | Combination therapy for treatment of psychoses |
WO1998028293A1 (en) * | 1996-12-20 | 1998-07-02 | H.Lundbeck A/S | Indane or dihydroindole derivatives |
WO2000023441A1 (en) * | 1998-10-16 | 2000-04-27 | Duphar International Research Bv | 3-tetrahydropyridin-4-yl indoles for treatment of psychotic disorders |
-
2000
- 2000-04-14 WO PCT/EP2000/003506 patent/WO2000069424A2/en not_active Application Discontinuation
- 2000-04-14 EP EP00926982A patent/EP1200072A2/en not_active Withdrawn
- 2000-04-14 AU AU45522/00A patent/AU4552200A/en not_active Abandoned
- 2000-04-14 CA CA002373855A patent/CA2373855A1/en not_active Abandoned
- 2000-04-14 JP JP2000617883A patent/JP2002544223A/en active Pending
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992012977A1 (en) * | 1991-01-28 | 1992-08-06 | Warner-Lambert Company | Substituted indoles as central nervous system agents |
EP0560669A1 (en) * | 1992-03-11 | 1993-09-15 | Bristol-Myers Squibb Company | Piperazinyl-and piperidinyl-cyclohexenes and cyclohexanes |
DE4414113A1 (en) * | 1994-04-22 | 1995-10-26 | Merck Patent Gmbh | 3-indolylpiperidines |
EP0722942A1 (en) * | 1995-01-12 | 1996-07-24 | MERCK PATENT GmbH | Indole piperidine derivatives |
WO1997017343A1 (en) * | 1995-11-06 | 1997-05-15 | American Home Products Corporation | Indolealkyl derivatives of benzodioxanmethylamine as 5-ht1a receptor ligands |
EP0830864A1 (en) * | 1996-09-23 | 1998-03-25 | Eli Lilly And Company | Combination therapy for treatment of psychoses |
WO1998028293A1 (en) * | 1996-12-20 | 1998-07-02 | H.Lundbeck A/S | Indane or dihydroindole derivatives |
WO2000023441A1 (en) * | 1998-10-16 | 2000-04-27 | Duphar International Research Bv | 3-tetrahydropyridin-4-yl indoles for treatment of psychotic disorders |
Non-Patent Citations (2)
Title |
---|
G.D. BARTOSZYK ET AL.: "EMD 86006: A SEROTONIN (5-HT) REUPTAKE INHIBITOR AND DOPAMIN DA-D2 ANTAGONIST", SOCIETY FOR NEUROSCIENCE ABSTRACTS, vol. 24, no. 1-2, 1998, pages 1112, XP000869625 * |
R. DAVIS ET AL.: "Ziprasidone", CNS DRUG, vol. 8, no. 2, 1997, pages 153 - 162, XP002127987 * |
Also Published As
Publication number | Publication date |
---|---|
CA2373855A1 (en) | 2000-11-23 |
EP1200072A2 (en) | 2002-05-02 |
AU4552200A (en) | 2000-12-05 |
JP2002544223A (en) | 2002-12-24 |
WO2000069424A2 (en) | 2000-11-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL377587A1 (en) | Hydroxyethylamine derivatives for the treatment of alzheimer's disease | |
WO2002053140A3 (en) | New drug combinations of norepinehrine reuptake inhibitors and neuroleptic agents | |
IL175819A0 (en) | Tricyclic indole hydroxyethylamine derivatives and their use in the treatment of alzheimer's disease | |
MY133238A (en) | Monoamine reuptake inhibitors for treatment for cns disorders | |
YU21702A (en) | Substituted indoles for modulating nfkb activity | |
HUP0201623A3 (en) | Use of (s,s)reboxetine a selective norepinephrine reuptake inhibitor for the preparation of pharmaceutical compositions treating disorders of the nervous system | |
NO20044501L (en) | [1,4] diazenino [6,7,1-IJ] quinoline derivatives such as antipsychotics and antidepressants | |
ZA200109073B (en) | Compositions for treatment of disorders of the oesophagus. | |
MX9602517A (en) | Naphthylamides as central nervous system agents. | |
WO2000069424A3 (en) | Method of treating psychotic disorders | |
WO2002044170A3 (en) | Benzothiophene derivative compounds, process of preparation and use thereof | |
AU7538200A (en) | Sapogenin derivatives and their use in the treatment of cognitive dysfunction | |
UA72948C2 (en) | Substituted derivatives of phenylpiperazine, a pharmaceutical composition and a method for treatment of affective or neurologic diseases and disorders | |
CA2474510A1 (en) | Fused tricyclic heterocycles useful for treating hyper-proliferative disorders | |
WO2003087062A3 (en) | 4-(heterocyclyl)-benzenesulfoximine compounds for the treatment of inflammation | |
IL172134A0 (en) | Use of 2,2,3,3, tetramethylcyclopropane carboxylic acid derivatives for treating psychiatric disorders | |
AU2002365288A1 (en) | Tropane derivatives having dopamine reuptake inhibitor activity for the treatment of ischemic diseases | |
WO2001007431A3 (en) | Benzothiophene derivatives | |
AU2003213896A1 (en) | Process to obtain dibenzylbutyrolactonic lignans; process to obtain synthetic derivatives from lignanes bearing anti-chagas chemoprophylactic and therapeutical activities | |
WO2001023385A3 (en) | Novel tropane analogs | |
NO20035642D0 (en) | Process for the preparation of derivatives of 1,5-diaryl-3-trifluoromethyl-delta-2-pyrazolines which are racemically and enantiomerically pure | |
MXPA05009763A (en) | 2-(butyl-1 -sulfonylamino) -n-[1(r) -(6-methoxy -pyridin -3-yl)- propyl] -benzamid, the use thereof in the form of drug an pharmaceutical preparations containing said compound. | |
AU6385200A (en) | Compositions, kits, and methods for prognostication, diagnosis, prevention, and treatment of bone-related disorders and other disorders | |
WO2002046163A3 (en) | Quinoline derivatives and their use as anti-epileptics | |
CA2387394A1 (en) | Use of 1-aminoindan derivatives for treatment of mania in bipolar mood disorder |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 2000 617883 Kind code of ref document: A Format of ref document f/p: F |
|
ENP | Entry into the national phase |
Ref document number: 2373855 Country of ref document: CA Ref country code: CA Ref document number: 2373855 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2000926982 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2000926982 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09959933 Country of ref document: US |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2000926982 Country of ref document: EP |